Literature DB >> 19011563

Plasmacytoid urothelial carcinoma: detailed analysis of morphology with clinicopathologic correlation in 17 cases.

Priya Nigwekar1, Pheroze Tamboli, Mitual B Amin, Adeboye O Osunkoya, David Ben-Dor, Mahul B Amin.   

Abstract

The plasmacytoid variant of urothelial carcinoma is rare, of which less than 40 cases have been reported in the English language literature. Herein we report the largest series to date of 17 cases of urothelial carcinoma with plasmacytoid features and report the associated clinicopathologic findings. The architectural pattern of the tumor varied from cells arranged in cords and single cells (35%), small nests (17%), solid sheetlike growth (29%), and diffuse discohesive patternless architecture (23%). The plasmacytoid component varied from 15% to 100% of the specimen analyzed; in 12 cases the plasmacytoid component composed greater than 50% of the tumor. The individual tumor cells had striking morphologic overlap with plasma cells with an eccentrically placed nucleus and abundant amphophilic to eosinophilic cytoplasm. The nuclei were of low to intermediate nuclear grade with minimal nuclear pleomorphism. Thirteen of 17 cases (76%) were associated with conventional high-grade invasive urothelial carcinoma and 9 cases showed very focal intracytoplasmic vacuoles mimicking signet ring cells. One case also showed sarcomatoid dedifferentiation. The tumor cells were positive for cytokeratin 7 (94%) and cytokeratin 20 (31%); CD138 was positive in 94% of cases. All cases were invasive -- 7 into at least the lamina propria, 7 into at least the muscularis propria, and 3 into perivesical fat. Follow-up information was available in 16 cases (range: 2 wk to 43 mo; mean 10 mo; median 5.5 mo). Eleven patients died of disease and 5 patients were alive with disease. Plasmacytoid variant of urothelial carcinoma is an aggressive subtype associated with poor prognosis. In limited samples, it may be misdiagnosed as chronic cystitis or plasmacytoma, a pitfall further compounded by CD138 expression. Distinction from metastatic carcinoma from other primary sites such as stomach and breast is critical due to differing therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19011563     DOI: 10.1097/PAS.0b013e318186c45e

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  29 in total

1.  Frequent somatic CDH1 loss-of-function mutations in plasmacytoid variant bladder cancer.

Authors:  Hikmat A Al-Ahmadie; Gopa Iyer; Byron H Lee; Sasinya N Scott; Rohit Mehra; Aditya Bagrodia; Emmet J Jordan; Sizhi Paul Gao; Ricardo Ramirez; Eugene K Cha; Neil B Desai; Emily C Zabor; Irina Ostrovnaya; Anuradha Gopalan; Ying-Bei Chen; Samson W Fine; Satish K Tickoo; Anupama Gandhi; Joseph Hreiki; Agnès Viale; Maria E Arcila; Guido Dalbagni; Jonathan E Rosenberg; Bernard H Bochner; Dean F Bajorin; Michael F Berger; Victor E Reuter; Barry S Taylor; David B Solit
Journal:  Nat Genet       Date:  2016-02-22       Impact factor: 38.330

2.  Transition between urothelial carcinoma in situ and non-invasive micropapillary carcinoma as a pivot connection between diverse morphologies of bladder carcinoma: a case report of urothelial carcinoma with villoglandular differentiation.

Authors:  Shogo Tajima; Kenji Koda
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

3.  [Not Available].

Authors:  Mohamed Hicham Benazzouz; Younes Essatara; Hachem Elsayegh; Ali Iken; Lounis Benslimane; Kaoutar Znati; Yassine Nouini
Journal:  Can Urol Assoc J       Date:  2014-09       Impact factor: 1.862

4.  Bladder Stones Associated with an Aggressive Plasmacytoid Variant of Urothelial Cancer: A Rare Case and Literature Review.

Authors:  Mohammed Alsheikh; Mohammad Faruquz Zaman; Preethi Gopinath; Ahmed Qteishat
Journal:  Curr Urol       Date:  2020-01-07

5.  Plasmacytoid urothelial carcinoma (PUC): Imaging features with histopathological correlation.

Authors:  Andrew D Chung; Nicola Schieda; Trevor A Flood; Ilias Cagiannos; Kien T Mai; Shawn Malone; Christopher Morash; Shaheed W Hakim; Rodney H Breau
Journal:  Can Urol Assoc J       Date:  2017-01-12       Impact factor: 1.862

6.  Invasive urothelial carcinoma with chordoid features may be an ominous sign predicting sarcomatoid change: a case report of a bladder carcinoma.

Authors:  Shogo Tajima; Tomoyuki Suzuki; Yukio Yamada; Teppei Morikawa; Daisuke Minagawa; Yukio Homma; Masashi Fukayama
Journal:  Med Mol Morphol       Date:  2015-02-18       Impact factor: 2.309

7.  Plasmacytoid urothelial carcinoma, a chemosensitive cancer with poor prognosis, and peritoneal carcinomatosis.

Authors:  Farshid Dayyani; Bogdan A Czerniak; Kanishka Sircar; Mark F Munsell; Randall E Millikan; Colin P Dinney; Arlene O Siefker-Radtke
Journal:  J Urol       Date:  2012-11-15       Impact factor: 7.450

Review 8.  Updates on the Genetics and Molecular Subtypes of Urothelial Carcinoma and Select Variants.

Authors:  Hikmat Al-Ahmadie; Gopa Iyer
Journal:  Surg Pathol Clin       Date:  2018-10-17

Review 9.  Variant Histology in Bladder Cancer-Current Understanding of Pathologic Subtypes.

Authors:  Manju Aron
Journal:  Curr Urol Rep       Date:  2019-11-28       Impact factor: 3.092

10.  Plasmacytoid urothelial carcinoma of the urinary bladder: a clinical pathological study and literature review.

Authors:  Zhihua Wang; Tong Lu; Lihuan Du; Zhiquan Hu; Qianyuan Zhuang; Youyuan Li; Cong-Yi Wang; Hui Zhu; Zhangqun Ye
Journal:  Int J Clin Exp Pathol       Date:  2012-07-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.